Cellular In Vitro Systems to Predict Chemically Induced Adverse Reactions in Humans-Reference-Cited by-同舟云学术

Cellular In Vitro Systems to Predict Chemically Induced Adverse Reactions in Humans

Published:2023-12 Issue:14 Volume:23 Page:1679-1680
ISSN:1871-5303
Container-title:Endocrine, Metabolic & Immune Disorders - Drug Targets
language:en
Short-container-title:EMIDDT

Author:

Orhan Hilmi¹

Affiliation:

1. Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Bornova-İzmir, Izmir Biomedicine and Genome Center (İBG-İzmir), Balcova 35340 /Türkiye

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference7 articles.

1. Maddalon A.; Iulini M.; Melzi G.; Corsini E.; Galbiati V.; New approach methodologies in immunotoxicology: challenges and opportunities. Endocr Metab Immune Disord Drug Targets 2023,23(14),1681-1698

2. Javed A.; Özduman G.; Altun S.; Duran D.; Yerli D.; Özar T.; Şimşek F.; Korkmaz K.S.; Mitotic kinase inhibitors as therapeutic interventions for prostate cancer: evidence from in vitro studies. Endocr Metab Immune Disord Drug Targets 2023,23(14),1699-1712

3. Karabicici M.; Akbari S.; Ertem O.; Gumustekin M.; Erdal E.; Human liver organoid models for assessment of drug toxicity at the preclinical stage. Endocr Metab Immune Disord Drug Targets 2023,23(14),1713-1724

4. Ergüç A.; Karakuş F.; Arzuk E.; Mutlu N.; Orhan H.; Role of oxidative stress and reactive metabolites in cytotoxicity and mitotoxicity of clozapine, diclofenac and nifedipine in cho-k1 cells in vitro. Endocr Metab Immune Disord Drug Targets 2023,23(14),1725-1739

5. Entezari B.; Bozdag D.; Gurer-Orhan H.; Evaluation of endocrine related adverse effects of non-endocrine targeted pharmaceuticals in cellular systems. Endocr Metab Immune Disord Drug Targets 2023,23(14),1740-1749